Tamoxifen therapy for the management of pubertal gynecomastia: A systematic review

Journal of Pediatric Endocrinology and Metabolism

Volumn 26, Issue 9-10, 2013, Pages 803-807

  Lapid, Oren ^a   Van Wingerden, Jan J ^a   Perlemuter, Leon ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Adolescent; Breast; Gynecomastia; Male; Puberty; Tamoxifen

Indexed keywords

DANAZOL; ESTRADIOL; RALOXIFENE; SEX HORMONE BINDING GLOBULIN; SEX HORMONE BINDING PROTEIN; TAMOXIFEN; TESTOSTERONE;

ABSENCE OF SIDE EFFECTS; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG USE; ESTRADIOL BLOOD LEVEL; GYNECOMASTIA; HUMAN; PROSPECTIVE STUDY; PUBERTY DISORDERS; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ESTROGEN ANTAGONISTS; EVIDENCE-BASED MEDICINE; GYNECOMASTIA; HUMANS; MALE; OFF-LABEL USE; TAMOXIFEN;

EID: 84888158749     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2013-0052     Document Type: Review

References (18)

1. Rohrich RJ, Ha RY, Kenkel JM, Adams WP Jr. Classification and management of gynecomastia: defining the role of ultrasoundassisted liposuction. Plast Reconstr Surg 2003;111:909-23, 924-5.
2. Braunstein GD. Clinical practice. Gynecomastia. N Engl J Med 2007;357: 1229-37.
3. Nordt CA, Divasta AD. Gynecomastia in adolescents. Curr Opin Pediatr 2008;20: 375-82.
4. Neuman JF. Evaluation and treatment of gynecomastia. Am Fam Physician 1997;55:1835-44, 1849-50.
5. Devalia HL, Layer GT. Current concepts in gynaecomastia. Surgeon 2009;7: 114-9.
6. Fairlamb D, Boesen E. Gynaecomastia associated with gonadotrophin- secreting carcinoma of the lung. Postgrad Med J 1977;53: 269-71.
7. Kunath F, Keck B, Antes G, Wullich B, Meerpohl JJ. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Med 2012;10:96.
8. Viani GA, Bernardes Da Silva LG, Stefano EJ. Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy? Int J Radiat Oncol Biol Phys 2012;83: e519-24.
9. Alagaratnam TT. Treating puberty gynecomastia. J R Coll Gen Pract 1987;37:178.
10. Derman O, Kanbur N, Kutluk T. Tamoxifen treatment for pubertal gynecomastia. Int J Adolesc Med Health 2003;15: 359-63.
11. Derman O, Kanbur N, Tokur TE. The effect of tamoxifen on sex hormone binding globulin in adolescents with pubertal gynecomastia. J Pediatr Endocrinol Metabol 2004:17: 1115-19.
12. Derman O, Kanbur N, Kilic I, Kutluk T. Long-term follow-up of tamoxifen treatment in adolescents with gynecomastia. J Pediatr Endocrinol Metabol 2008;21: 449-54.
13. König R, Schönberger W, Neumann P, Benes P, Grimm W. Treatment of marked pubertal gynecomastia with tamoxifen. Klin Padiatr 1987;199: 389-91.
14. Lawrence SE, Faught KA, Vethamuthu J, Lawson ML. Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. J Pediatr 2004;145: 71-6.
15. Caceres Narizzano O. Diagnosis and treatment of gynecomastia. [Spanish] Diagnostico Y Terapeutica De Las Ginecomastias. Endocrinologia 1995;42:61.
16. Sullivan D, Chung KC, Eaves FF 3rd, Rohrich RJ. The level of evidence pyramid: indicating levels of evidence in Plastic and Reconstructive Surgery articles. Plast Reconstr Surg 2011;128: 311-4.
17. Nydick M, Bustos J, Dale JH Jr., Rawson RW. Gynecomastia in adolescent boys. J Am Med Assoc 1961;178: 449-54.
18. Kreher NC, Eugster EA, Shankar RR. The use of tamoxifen to improve height potential in short pubertal boys. Pediatrics 2005;116: 1513-5.